Daratumumab (Vials) 400mg/20ml

Daratumumab 400mg/20ml vials are used for certain blood cancer treatments. This monoclonal antibody supports therapy under medical supervision. Ideal for oncology regimens requiring targeted immune response. Store at ambient temperature for stability.

Strength

400mg/20ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Jannsen

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Daratumumab 400mg/20ml vials are prescribed to treat multiple myeloma and other plasma cell disorders. It works by targeting CD38 proteins on cancer cells to reduce disease progression. Often used alongside other chemotherapy agents in clinical settings. Patients may ask, what is daratumumab used for in cancer care.

Side Effects

Daratumumab may cause infusion-related reactions during administration, such as chills or nausea. Some patients report fatigue or respiratory symptoms afterward. These effects vary by individual and treatment stage. Monitoring is recommended during therapy sessions.

Precautions & Warnings

Handle daratumumab vials with care to avoid contamination or spills. Use aseptic technique during preparation and administration. Discard unused portions properly to prevent exposure. Healthcare professionals should follow biosafety guidelines for handling.

Avoid Interactions

Daratumumab may interact with other immunosuppressants or live vaccines, altering effectiveness. Caution is advised when combining with medications affecting immune response. Avoid alcohol during treatment as it may worsen side effects. Always disclose all medications to your provider.

Frequently Asked Questions

Daratumumab is used to treat certain blood cancers like multiple myeloma by targeting specific proteins on cancer cells.

Daratumumab is given as an intravenous infusion under medical supervision in a clinical setting.

Common effects include infusion reactions like chills, fatigue, and respiratory symptoms during or after treatment.

Yes, daratumumab vials should be stored at ambient temperature as indicated on the packaging.

Daratumumab may interact with immunosuppressants or live vaccines; consult your healthcare provider for details.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.